TOP

Online First

Case Report
Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia
Shoya Arai1, Kensuke Matsumoto1, Haruko Tashiro1, Seiko Kato2, Takaaki Konuma2, Jun Ooi3,4

1Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan

2Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

3Department of Transfusion Medicine and Cell-processing, Teikyo University School of Medicine, Tokyo, Japan

4Department of Clinical Laboratory Science, Teikyo University, Tokyo, Japan

Keywords
allogeneic stem cell transplantation, cord blood transplantation, chronic myelomonocytic leukemia, immune thrombocytopenia
Submitted: March 6, 2024
Accepted: March 31, 2025
Published online: July 4, 2025

Abstract

Several reports have been published on autoimmune hematologic complications, including immune thrombocytopenia (ITP), after cord blood transplantation (CBT). However, there have been no reports of late-onset ITP following CBT. A 51-year-old male with chronic myelomonocytic leukemia received unrelated CBT in 2012. During regular follow-up visits every 3-6 months, his complete blood count remained normal until March 2024. In September 2024, 12 years after the CBT, the patient suddenly developed severe thrombocytopenia. Following a diagnosis of ITP, the patient was treated with intravenous immunoglobulins and prednisone. With follow-up period of 5 months after the onset of ITP, the patient is still alive with a platelet count of 126 × 109/L. This case suggests that late-onset ITP after CBT occurred suddenly and may be life-threatening. Long-term follow-ups and regular clinic visits may reduce the risk of delays in diagnosis and treatment.

PDF

Search

Volume / Issue
Article Type
Author
Search word

News

Online ISSN:2432-7026